Pluristem Therapeutics Inc. (NASDAQ: PSTI) announced that it received a notice today from United Therapeutics Corporation (“United”) ending its licensing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE